Abstract
In the present review, we provide a comprehensive summary of recent pharmacological studies on dopamine transporter (DAT) inhibitors, which are potential treatments for neurodegenerative and psychiatric disorders. Extensive structure-activity relationship studies have identified numerous tropane-based ligands with high affinity and selectivity for the DAT or with high affinity to the DAT and other monoamine transporters (dual and triple monoamine reuptake inhibitors). The review covers advances in the field in past fifteen years. Among the described compounds, many appear to be promising drug candidates, while other may serve as valuable tools for research or as prototypes for new classes of selective DAT inhibitors. Special attention is being paid to separation of the DAT inhibition from NET and SERT inhibition.
Keywords: ADHD, cocaine abuse, depression, dopamine transporter inhibitor, monoamine transporter inhibitor, tropane derivatives.
Current Medicinal Chemistry
Title:Progress in the Search for New Dopamine Transporter Inhibitors
Volume: 22 Issue: 28
Author(s): Beata Gryzlo, Paula Zareba, Katarzyna Malawska, Anna Jakubowska and Katarzyna Kulig
Affiliation:
Keywords: ADHD, cocaine abuse, depression, dopamine transporter inhibitor, monoamine transporter inhibitor, tropane derivatives.
Abstract: In the present review, we provide a comprehensive summary of recent pharmacological studies on dopamine transporter (DAT) inhibitors, which are potential treatments for neurodegenerative and psychiatric disorders. Extensive structure-activity relationship studies have identified numerous tropane-based ligands with high affinity and selectivity for the DAT or with high affinity to the DAT and other monoamine transporters (dual and triple monoamine reuptake inhibitors). The review covers advances in the field in past fifteen years. Among the described compounds, many appear to be promising drug candidates, while other may serve as valuable tools for research or as prototypes for new classes of selective DAT inhibitors. Special attention is being paid to separation of the DAT inhibition from NET and SERT inhibition.
Export Options
About this article
Cite this article as:
Gryzlo Beata, Zareba Paula, Malawska Katarzyna, Jakubowska Anna and Kulig Katarzyna, Progress in the Search for New Dopamine Transporter Inhibitors, Current Medicinal Chemistry 2015; 22 (28) . https://dx.doi.org/10.2174/0929867322666150812145631
DOI https://dx.doi.org/10.2174/0929867322666150812145631 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Novel Anxiolytic Drugs
Current Pharmaceutical Design Targets Involved in Cardioprotection by the Non-Anesthetic Noble Gas Helium
Current Drug Targets The Role of Continuous Positive Airway Pressure in the Treatment of Hypertension in Patients with Obstructive Sleep Apnea-Hypoapnea Syndrome: A Review of Randomized Trials
Reviews on Recent Clinical Trials Proteomic Analysis of Glioma Chemoresistance
Current Neuropharmacology An Overview of the Pharmacogenetics and Molecular Genetics of ADHD
Current Pharmacogenomics Growing Use of Conventional Methods for Preparation of Scaffolds for Bone Tissue Engineering
Current Applied Polymer Science Patterns of Cognitive Impairment in Neurological Disease
Current Psychiatry Reviews Effectiveness of Psychoeducational Interventions for Improving Symptoms, Health-Related Quality of Life, and Psychological well Being in Patients with Stable Angina
Current Cardiology Reviews Hepatic Effects of Duloxetine-I: Non-Clinical and Clinical Trial Data
Current Drug Safety Editorial: Adolescent Psychiatry — Past, Present, and Future
Adolescent Psychiatry Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches
Current Medicinal Chemistry Role of T Lymphocytes in the Development of Rheumatoid Arthritis. Implications for Treatment
Current Pharmaceutical Design Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Role of Stromal-Derived Factor-1 in Mesenchymal Stem Cell Paracrinemediated Tissue Repair
Current Stem Cell Research & Therapy Involvement of Toll-like Receptors in Ischemia-induced Neuronal Damage
Central Nervous System Agents in Medicinal Chemistry Atomic Force Microscopy: The Characterisation of Amyloid Protein Structure in Pathology
Current Topics in Medicinal Chemistry No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes
Current Alzheimer Research Major CYP450 Polymorphism among Saudi Patients
Drug Metabolism Letters Editorial: Seeking Answers to Questions in Adolescent Psychiatry
Adolescent Psychiatry Fragile X Mental Retardation Protein: Past, Present and Future
Current Protein & Peptide Science